Connection

Prabhakar Baliga to Female

Back to Details
This is a "connection" page, showing publications Prabhakar Baliga has written about Female.
Prabhakar Baliga
Connection Strength
1.521
Female
  1. Facilitated Regional Collaboration and In-Hospital Surgical Complication. J Am Coll Surg. 2021 04; 232(4):536-543.
    View in: PubMed
    Score: 0.039
  2. Maintaining Equity and Access: Successful Implementation of a Virtual Kidney Transplantation Evaluation. J Am Coll Surg. 2021 04; 232(4):444-449.
    View in: PubMed
    Score: 0.039
  3. The non-directed living kidney donor: Why donate to strangers? J Ren Care. 2019 Jun; 45(2):102-110.
    View in: PubMed
    Score: 0.034
  4. South Carolina Surgical Quality Collaborative Colon Surgery Outcomes Vary by Age and Race. Am Surg. 2018 Aug 01; 84(8):1312-1313.
    View in: PubMed
    Score: 0.033
  5. Feasibility and Functional Testing for Frailty in Chronic Kidney Disease. Prog Transplant. 2018 09; 28(3):299-300.
    View in: PubMed
    Score: 0.033
  6. Transplant Center Variability in Disparities for African-American Kidney Transplant Recipients. Ann Transplant. 2018 Feb 16; 23:119-128.
    View in: PubMed
    Score: 0.032
  7. Association of Pretransplantion Opioid Use with Graft Loss or Death in Liver Transplantation Patients with Model of End-Stage Liver Disease Exceptions. J Am Coll Surg. 2018 04; 226(4):651-659.
    View in: PubMed
    Score: 0.032
  8. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017 12; 101(12):2931-2938.
    View in: PubMed
    Score: 0.031
  9. Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant Recipients. Ann Surg. 2017 09; 266(3):450-456.
    View in: PubMed
    Score: 0.031
  10. Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney Transplantation. J Am Coll Surg. 2017 Apr; 224(4):585-592.
    View in: PubMed
    Score: 0.030
  11. Social Media Use Among Living Kidney Donors and Recipients: Survey on Current Practice and Potential. J Med Internet Res. 2016 12 20; 18(12):e328.
    View in: PubMed
    Score: 0.029
  12. Outcome disparities between African Americans and Caucasians in contemporary kidney transplant recipients. Am J Surg. 2017 Apr; 213(4):666-672.
    View in: PubMed
    Score: 0.029
  13. A patient navigator and education program for increasing potential living donors: a comparative observational study. Clin Transplant. 2016 05; 30(5):619-27.
    View in: PubMed
    Score: 0.028
  14. Health literacy and kidney transplant outcomes. Prog Transplant. 2015 Mar; 25(1):85-90.
    View in: PubMed
    Score: 0.026
  15. Inclusion of dynamic clinical data improves the predictive performance of a 30-day readmission risk model in kidney transplantation. Transplantation. 2015 Feb; 99(2):324-30.
    View in: PubMed
    Score: 0.026
  16. African American patient knowledge of kidney disease: A qualitative study of those with advanced chronic kidney disease. Chronic Illn. 2015 Dec; 11(4):245-55.
    View in: PubMed
    Score: 0.025
  17. Variations in coping stages for individuals with chronic kidney disease: Results from an exploratory study with patient navigators. J Health Psychol. 2016 07; 21(7):1299-310.
    View in: PubMed
    Score: 0.025
  18. Development and testing of a disease-specific health literacy measure in kidney transplant patients. Prog Transplant. 2014 Sep; 24(3):263-70.
    View in: PubMed
    Score: 0.025
  19. Health care provider perception of chronic kidney disease: knowledge and behavior among African American patients. BMC Nephrol. 2014 Jul 10; 15:112.
    View in: PubMed
    Score: 0.025
  20. The concept of a composite perioperative quality index in kidney transplantation. J Am Coll Surg. 2014 Apr; 218(4):588-97.
    View in: PubMed
    Score: 0.024
  21. Racial comparisons of everolimus pharmacokinetics and pharmacodynamics in adult kidney transplant recipients. Ther Drug Monit. 2013 Dec; 35(6):753-9.
    View in: PubMed
    Score: 0.024
  22. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013 Sep-Oct; 27(5):732-41.
    View in: PubMed
    Score: 0.023
  23. Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation. Prog Transplant. 2013 Mar; 23(1):33-8.
    View in: PubMed
    Score: 0.023
  24. Improving the perioperative value of care for vulnerable kidney transplant recipients. J Am Coll Surg. 2013 Apr; 216(4):668-76; discussion 676-8.
    View in: PubMed
    Score: 0.022
  25. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013 Mar; 13(3):796-801.
    View in: PubMed
    Score: 0.022
  26. Medication errors and adverse drug events in kidney transplant recipients: incidence, risk factors, and clinical outcomes. Pharmacotherapy. 2012 Dec; 32(12):1053-60.
    View in: PubMed
    Score: 0.022
  27. Barriers facing patients referred for kidney transplant cause loss to follow-up. Kidney Int. 2012 Nov; 82(9):1018-23.
    View in: PubMed
    Score: 0.022
  28. Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients. Am J Med Qual. 2013 Mar-Apr; 28(2):103-12.
    View in: PubMed
    Score: 0.022
  29. Graft outcomes in pediatric kidney transplantation: focus on the role of race. Saudi J Kidney Dis Transpl. 2012 Jul; 23(4):684-92.
    View in: PubMed
    Score: 0.022
  30. Generic immunosuppression: deciphering the message our patients are receiving. Ann Pharmacother. 2012 May; 46(5):671-7.
    View in: PubMed
    Score: 0.021
  31. Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1003-9.
    View in: PubMed
    Score: 0.021
  32. Case report: gastrointestinal hemorrhage caused by a pancreas transplant arteriovenous fistula with large psuedoanuerysm 9 years after transplantation. Transplant Proc. 2011 Dec; 43(10):4039-43.
    View in: PubMed
    Score: 0.021
  33. A critical analysis of racial difference with mycophenolate mofetil (MMF) dosing, clinical outcomes and adverse effects in pediatric kidney transplant patients. Clin Transplant. 2011 Jul-Aug; 25(4):534-40.
    View in: PubMed
    Score: 0.019
  34. Potential differences in kidney allograft outcomes between ethnicities when converting to sirolimus base immunosuppression. Transplant Proc. 2009 Dec; 41(10):4131-7.
    View in: PubMed
    Score: 0.018
  35. Comparison of efficacy of induction therapy in low immunologic risk African-American kidney transplant recipients. Transpl Int. 2010 May 01; 23(5):500-5.
    View in: PubMed
    Score: 0.018
  36. Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):40-7.
    View in: PubMed
    Score: 0.017
  37. Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantation. Transplant Proc. 2008 Dec; 40(10):3401-7.
    View in: PubMed
    Score: 0.017
  38. Racial differences in the living kidney donation experience and implications for education. Prog Transplant. 2007 Sep; 17(3):234-40.
    View in: PubMed
    Score: 0.015
  39. Inflammatory myofibroblastic tumor of the liver. J Hepatobiliary Pancreat Surg. 2007; 14(4):421-3.
    View in: PubMed
    Score: 0.015
  40. Can family attributes explain the racial disparity in living kidney donation? Transplant Proc. 2007 Jun; 39(5):1376-80.
    View in: PubMed
    Score: 0.015
  41. Use of bone health protocol to identify and prevent bone disease in kidney and pancreas transplant recipients. Ann Pharmacother. 2007 Jun; 41(6):944-50.
    View in: PubMed
    Score: 0.015
  42. Racial differences in coping with the need for kidney transplantation and willingness to ask for live organ donation. Am J Kidney Dis. 2006 Feb; 47(2):324-31.
    View in: PubMed
    Score: 0.014
  43. Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl. 2004 Nov; 10(11):1364-71.
    View in: PubMed
    Score: 0.013
  44. Transcatheter splenic artery occlusion for treatment of splenic artery steal syndrome after orthotopic liver transplantation. Cardiovasc Intervent Radiol. 2002 Jul-Aug; 25(4):300-6.
    View in: PubMed
    Score: 0.011
  45. The Perioperative Patient Experience During COVID-19. Am Surg. 2022 Mar; 88(3):498-506.
    View in: PubMed
    Score: 0.010
  46. A Dialysis Center Educational Video Intervention Increases Patient Self-Efficacy and Kidney Transplant Evaluations. Prog Transplant. 2022 03; 32(1):27-34.
    View in: PubMed
    Score: 0.010
  47. The impact of race on metabolic, graft, and patient outcomes after pancreas transplantation. Am J Surg. 2022 04; 223(4):812-816.
    View in: PubMed
    Score: 0.010
  48. Virtual Crossmatching in Kidney Transplantation: The Wait Is Over. J Am Coll Surg. 2020 04; 230(4):373-379.
    View in: PubMed
    Score: 0.009
  49. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor. Transplantation. 1999 Nov 15; 68(9):1369-76.
    View in: PubMed
    Score: 0.009
  50. Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. Clin Transplant. 2019 10; 33(10):e13701.
    View in: PubMed
    Score: 0.009
  51. Long-standing diabetes mellitus and pancreas transplantation: An avenue to increase utilization of an ideal treatment modality. Clin Transplant. 2019 10; 33(10):e13695.
    View in: PubMed
    Score: 0.009
  52. Development and future deployment of a 5 years allograft survival model for kidney transplantation. Nephrology (Carlton). 2019 Aug; 24(8):855-862.
    View in: PubMed
    Score: 0.009
  53. Impact of Type 1 and Type 2 Diabetes Mellitus on Pancreas Transplant Outcomes. Exp Clin Transplant. 2019 12; 17(6):796-802.
    View in: PubMed
    Score: 0.008
  54. Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant. Am J Transplant. 2019 01; 19(1):98-109.
    View in: PubMed
    Score: 0.008
  55. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade. Transplantation. 1998 Jul 15; 66(1):14-20.
    View in: PubMed
    Score: 0.008
  56. Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200?days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study. Transpl Infect Dis. 2017 Dec; 19(6).
    View in: PubMed
    Score: 0.008
  57. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient. Pharmacotherapy. 1997 Nov-Dec; 17(6):1328-30.
    View in: PubMed
    Score: 0.008
  58. Design and approach of the Living Organ Video Educated Donors (LOVED) program to promote living kidney donation in African Americans. Contemp Clin Trials. 2017 10; 61:55-62.
    View in: PubMed
    Score: 0.008
  59. Morbid obesity and functional status as predictors of surgical complication after renal transplantation. Am J Surg. 2018 Apr; 215(4):663-668.
    View in: PubMed
    Score: 0.008
  60. Effectiveness of an Evidence-Based Induction Therapy Protocol Revision in Adult Kidney Transplant Recipients. Pharmacotherapy. 2017 Jun; 37(6):692-699.
    View in: PubMed
    Score: 0.008
  61. Overall Graft Loss Versus Death-Censored Graft Loss: Unmasking the Magnitude of Racial Disparities in Outcomes Among US Kidney Transplant Recipients. Transplantation. 2017 Feb; 101(2):402-410.
    View in: PubMed
    Score: 0.007
  62. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial. Transplantation. 2017 Jan; 101(1):157-165.
    View in: PubMed
    Score: 0.007
  63. A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2017 01 06; 12(1):131-139.
    View in: PubMed
    Score: 0.007
  64. The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.
    View in: PubMed
    Score: 0.007
  65. Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation. Surgery. 2017 03; 161(3):830-836.
    View in: PubMed
    Score: 0.007
  66. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways. Transplantation. 1996 Oct 15; 62(7):1011-8.
    View in: PubMed
    Score: 0.007
  67. Intestinal transplantation: an early experience. Transplant Proc. 1996 Oct; 28(5):2734-5.
    View in: PubMed
    Score: 0.007
  68. Twenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int. 2016 10; 90(4):878-87.
    View in: PubMed
    Score: 0.007
  69. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension. 2016 09; 68(3):715-25.
    View in: PubMed
    Score: 0.007
  70. Quantifying the Race Stratified Impact of Socioeconomics on Graft Outcomes in Kidney Transplant Recipients. Transplantation. 2016 07; 100(7):1550-7.
    View in: PubMed
    Score: 0.007
  71. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching. Exp Clin Transplant. 2017 Feb; 15(1):47-55.
    View in: PubMed
    Score: 0.007
  72. Predicting and preventing readmissions in kidney transplant recipients. Clin Transplant. 2016 07; 30(7):779-86.
    View in: PubMed
    Score: 0.007
  73. A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients. Clin Transplant. 2016 05; 30(5):528-33.
    View in: PubMed
    Score: 0.007
  74. Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients. Pediatr Transplant. 2016 Feb; 20(1):44-8.
    View in: PubMed
    Score: 0.007
  75. Sustainability of improvements in medication adherence through a mobile health intervention. Prog Transplant. 2015 Sep; 25(3):217-23.
    View in: PubMed
    Score: 0.007
  76. Neurocognitive status is associated with all-cause mortality among psychiatric, high-risk liver transplant candidates and recipients. Int J Psychiatry Med. 2015; 49(4):279-95.
    View in: PubMed
    Score: 0.007
  77. African American kidney transplant patients' perspectives on challenges in the living donation process. Prog Transplant. 2015 Jun; 25(2):164-75.
    View in: PubMed
    Score: 0.007
  78. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy. 2015 Jun; 35(6):569-77.
    View in: PubMed
    Score: 0.007
  79. Prediction of medication non-adherence and associated outcomes in pediatric kidney transplant recipients. Pediatr Transplant. 2015 Aug; 19(5):555-62.
    View in: PubMed
    Score: 0.007
  80. Is cirrhosis a contraindication to laparoscopic cholecystectomy? Am Surg. 2015 Jan; 81(1):52-5.
    View in: PubMed
    Score: 0.006
  81. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity. Transplantation. 1994 Nov 27; 58(10):1082-90.
    View in: PubMed
    Score: 0.006
  82. Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis. J Gastrointest Surg. 2015 Feb; 19(2):282-9.
    View in: PubMed
    Score: 0.006
  83. Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014 Sep 27; 98(6):632-9.
    View in: PubMed
    Score: 0.006
  84. Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: a retrospective analysis. Blood Press. 2015 Feb; 24(1):14-22.
    View in: PubMed
    Score: 0.006
  85. Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients. Am J Nephrol. 2014; 40(1):19-28.
    View in: PubMed
    Score: 0.006
  86. The impact of diabetes mellitus and glycemic control on clinical outcomes following liver transplant for hepatitis C. Clin Transplant. 2014 Aug; 28(8):862-8.
    View in: PubMed
    Score: 0.006
  87. Clinical and economic outcomes associated with medication errors in kidney transplantation. Clin J Am Soc Nephrol. 2014 May; 9(5):960-6.
    View in: PubMed
    Score: 0.006
  88. Development and validation of a questionnaire to assess fear of kidney failure following living donation. Transpl Int. 2014 Jun; 27(6):570-5.
    View in: PubMed
    Score: 0.006
  89. Clinical outcomes associated with the early postoperative use of heparin in pancreas transplantation. Transplantation. 2014 Mar 27; 97(6):681-5.
    View in: PubMed
    Score: 0.006
  90. Association between patient satisfaction and outcomes in kidney transplant. Am J Med Qual. 2015 Mar-Apr; 30(2):180-5.
    View in: PubMed
    Score: 0.006
  91. Are thiazide diuretics safe and effective antihypertensive therapy in kidney transplant recipients? Am J Nephrol. 2013; 38(4):285-91.
    View in: PubMed
    Score: 0.006
  92. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation. Clin Transplant. 2013 Mar-Apr; 27(2):274-82.
    View in: PubMed
    Score: 0.006
  93. Patient attitudes toward mobile phone-based health monitoring: questionnaire study among kidney transplant recipients. J Med Internet Res. 2013 Jan 08; 15(1):e6.
    View in: PubMed
    Score: 0.006
  94. The impact of diabetes on ethnic disparities seen in kidney transplantation. Ethn Dis. 2013; 23(2):238-44.
    View in: PubMed
    Score: 0.006
  95. The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplant. J Cardiovasc Pharmacol Ther. 2013 May; 18(3):243-50.
    View in: PubMed
    Score: 0.006
  96. A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4399-406.
    View in: PubMed
    Score: 0.005
  97. Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation. Transplant Proc. 2013 Jan-Feb; 45(1):330-4.
    View in: PubMed
    Score: 0.005
  98. The impact of early corticosteroid withdrawal on graft survival in liver transplant recipients. Transplant Proc. 2012 Jun; 44(5):1323-8.
    View in: PubMed
    Score: 0.005
  99. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec; 17(12):1394-403.
    View in: PubMed
    Score: 0.005
  100. Analyses of renal outcome following transplantation adjusting for informative right censoring and demographic factors: A longitudinal study. Ren Fail. 2010 Jul; 32(6):691-8.
    View in: PubMed
    Score: 0.005
  101. Can preemptive cytomegalovirus monitoring be as effective as universal prophylaxis when implemented as the standard of care in patients at moderate risk? Transplantation. 2010 May 27; 89(10):1218-23.
    View in: PubMed
    Score: 0.005
  102. The use of drotrecogin alfa (activated) in solid organ transplant patients: a case series. Transpl Infect Dis. 2009 Jun; 11(3):269-76.
    View in: PubMed
    Score: 0.004
  103. No difference between smokers, former smokers, or nonsmokers in the operative outcomes of laparoscopic donor nephrectomies. Surg Laparosc Endosc Percutan Tech. 2009 Apr; 19(2):153-6.
    View in: PubMed
    Score: 0.004
  104. Laparoscopic hepatic resection: the MUSC experience. J S C Med Assoc. 2008 Dec; 104(8):244-6.
    View in: PubMed
    Score: 0.004
  105. Parenchymal transection of the kidney inflicted by endocatch bag entrapment during a laparoscopic donor nephrectomy. Am J Transplant. 2006 Jan; 6(1):232-5.
    View in: PubMed
    Score: 0.003
  106. Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5.
    View in: PubMed
    Score: 0.003
  107. Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease. Transpl Infect Dis. 2004 Sep; 6(3):101-9.
    View in: PubMed
    Score: 0.003
  108. Long-term outcome of sirolimus rescue in kidney-pancreas transplantation. Transplantation. 2004 Aug 27; 78(4):619-22.
    View in: PubMed
    Score: 0.003
  109. Does treatment of cadaveric organ donors with desmopressin increase the likelihood of pancreas graft thrombosis? Results of a preliminary study. Transplant Proc. 2004 May; 36(4):1048-9.
    View in: PubMed
    Score: 0.003
  110. Influence of mild obesity on outcome of simultaneous pancreas and kidney transplantation. J Gastrointest Surg. 2003 Dec; 7(8):1096-101.
    View in: PubMed
    Score: 0.003
  111. Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant. 2003 Nov; 18(11):2436-8.
    View in: PubMed
    Score: 0.003
  112. Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation. Am J Transplant. 2003 Oct; 3(10):1278-88.
    View in: PubMed
    Score: 0.003
  113. Chylous ascites secondary to laparoscopic donor nephrectomy. Urology. 2002 Aug; 60(2):345.
    View in: PubMed
    Score: 0.003
  114. Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated recovery. Clin Transplant. 2001; 15 Suppl 6:59-61.
    View in: PubMed
    Score: 0.002
  115. Laparoscopic donor nephrectomy: impact on an established renal transplant program. Am Surg. 2000 Dec; 66(12):1132-5.
    View in: PubMed
    Score: 0.002
  116. Cyclosporine-induced hemolytic uremic syndrome and hemorrhagic colitis following renal transplantation. Clin Transplant. 1999 Dec; 13(6):526-30.
    View in: PubMed
    Score: 0.002
  117. Differential effects of transferrin receptor blockade on the cellular mechanisms involved in graft rejection. Transpl Immunol. 1999 Sep; 7(3):131-9.
    View in: PubMed
    Score: 0.002
  118. Transferrin receptor in T cell activation and transplantation. J Leukoc Biol. 1998 Jul; 64(1):19-24.
    View in: PubMed
    Score: 0.002
  119. The first 50 pancreas transplants in South Carolina. J S C Med Assoc. 1997 Oct; 93(10):367-72.
    View in: PubMed
    Score: 0.002
  120. Effect of race on outcome after kidney and kidney-pancreas transplantation in type 1 diabetic patients. Diabetes Care. 1997 Aug; 20(8):1310-4.
    View in: PubMed
    Score: 0.002
  121. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function. Clin Transplant. 1997 Aug; 11(4):294-8.
    View in: PubMed
    Score: 0.002
  122. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology. 1996 Sep; 111(3):710-5.
    View in: PubMed
    Score: 0.002
  123. The effects of prostaglandin E1 on hepatic allograft vascular inflow: a prospective randomized double-blind study. Am Surg. 1996 Mar; 62(3):184-7.
    View in: PubMed
    Score: 0.002
  124. Failure of dialysis access: revise or replace? J Surg Res. 1996 Feb 01; 60(2):312-6.
    View in: PubMed
    Score: 0.002
  125. Stress steroids are not required for patients receiving a renal allograft and undergoing operation. J Am Coll Surg. 1995 May; 180(5):532-6.
    View in: PubMed
    Score: 0.002
  126. Anti-CD48 (murine CD2 ligand) mAbs suppress cell mediated immunity in vivo. Int Immunol. 1994 May; 6(5):701-9.
    View in: PubMed
    Score: 0.002
  127. Valve bladder does not affect the outcome of renal transplants in children with renal failure due to posterior urethral valves. Transplant Proc. 1994 Feb; 26(1):115-6.
    View in: PubMed
    Score: 0.002
  128. New patterns of transplant nephrectomy in the cyclosporine era. J Am Coll Surg. 1994 Jan; 178(1):59-64.
    View in: PubMed
    Score: 0.001
  129. Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production. Ann Surg. 1993 Oct; 218(4):492-501; discussion 501-3.
    View in: PubMed
    Score: 0.001
  130. Aortic revascularization of orthotopic liver allografts: indications and long-term follow-up. Surgery. 1993 Mar; 113(3):279-85.
    View in: PubMed
    Score: 0.001
  131. Renal dysfunction in hepatic disease: early identification with renal duplex Doppler US in patients who undergo liver transplantation. Radiology. 1992 Jun; 183(3):801-6.
    View in: PubMed
    Score: 0.001
  132. Early immunological benefits of glutathione-supplemented UW solution in hepatic transplantation. Transplant Proc. 1991 Aug; 23(4):2243-5.
    View in: PubMed
    Score: 0.001
  133. Virulence of wild-type E. coli uroisolates in experimental pyelonephritis. Kidney Int. 1988 Dec; 34(6):761-5.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.